1-4 of 4
Andreu Llorente, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Impact Of European Leukemia Net (ELN) Genetic Classification On The Outcome Of Allogeneic Stem Cell Transplantation (ALLOHCT) For Acute Myeloid Leukemia (AML) In First Complete Remission

Jorge Sierra, PhD, MD, Ana Garrido, MD, Mar Tormo, MD, Ramon Guardia, MD, Josep F Nomdedeu, MD, Jordi Esteve, MD, PhD, Josep-Maria Ribera, MD, PhD, Rafael F. Duarte, MD, PhD, M. Paz Queipo De Llano, MD, Olga Salamero, MD, Carmen Pedro, MD, Joan Bargay, MD, Juan Besalduch, MD, PhD, Andreu Llorente, MD, Montserrat Hoyos, Montserrat Arnan, MD, Marta Pratcorona, MD, Susana Vives, MD, Marisa Calabuig, MD, David Gallardo, MD, PhD, Salut Brunet, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2107.
https://doi.org/10.1182/blood.V122.21.2107.2107
Published: 2013
Journal Articles

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Classical Risk Factors and Minimal Residual Disease (MRD). Interim Results of the PETHEMA ALL-AR-03 Trial.

Josep Ribera, MD, Albert Oriol, MD, Mireia Morgades, MD, Josep Sarrá, MD, Salut Brunet, MD, Andreu Llorente, MD, Ramon Guardia, MD, Ricardo Parody, MD, Teresa Bernal, MD, Jordi Esteve, MD, Miguel Sanz, MD, Eloy Del Potro, MD, Juan Bergua, MD, Maria-Jose Moreno, MD, Carlos Grande, MD, Javier Bueno, MD, Antonia Cladera, MD, María-Carmen Fernández, MD, Raimundo García-Boyero, MD, Arancha Bermúdez, MD, Evarist Feliu, MD
Journal: Blood
Blood (2006) 108 (11): 1872.
https://doi.org/10.1182/blood.V108.11.1872.1872
Published: 2006
Journal Articles

Germline Polymorphisms Provide Strong Prognostic Information in Intermediate Risk Acute Myeloblastic Leukemia (AML).

Alvaro Urbano-Ispizua, MD, Salut Brunet, MD, Mariano Monzo, MD, PhD, Granada Perea, MD, Alfons Navarro, PhD, Jordi Esteve, MD, Juan Berlanga, MD, Josep-Maria Ribera, MD, Javier Bueno, MD, Andreu Llorente, MD, Juan Besalduch, MD, Ramon Guardia, MD, Mar Tormo, MD, Carmen Pedro, MD, Juan-Maria Sanchez, MD, Pio Torres, MD, Maria-Paz Queipo de Llano, MD, Llorens Font, MD, Jose-Maria Moraleda, MD, Josep-Maria Marti, MD, Pilar Vivancos, MD, Maria-Jesus Peñarubia, MD, Josep Nomdedeu, MD, Emili Montserrat, MD, Jorge Sierra, MD
Journal: Blood
Blood (2004) 104 (11): 398.
https://doi.org/10.1182/blood.V104.11.398.398
Published: 2004
Journal Articles

Minimal Residual Disease (MRD) Analysis in Acute Myeloid Leukemia (AML) with Favorable Cytogenetics [t(8;21) and inv(16)] by Real Time PCR(RT-PCR) and Flow Cytometry (FC).

Granada Perea, MD, Adriana Lasa, PhD, Anna Aventin, MD, Alicia Domingo, MD, Neus Villamor, MD, Maria Paz Queipo de LLano, MD, Andreu Llorente, MD, Jordi Junca, MD, Carlos Palacios, MD, Cristalina Fernandez, MD, Miquel Guallart, MD, Llorens Font, MD, Mar Tormo, MD, Lourdes Florensa, MD, Joan Bargay, MD, Josep M. Marti, MD, Pilar Vivancos, MD, Pio Torres, MD, Juan Berlanga, MD, Salut Brunet, MD, Jorge Sierra, MD, Josep F. Nomdedeu, MD
Journal: Blood
Blood (2004) 104 (11): 2989.
https://doi.org/10.1182/blood.V104.11.2989.2989
Published: 2004